We have compiled a list of manufacturers, distributors, product information, reference prices, and rankings for Fibrosis drug.
ipros is IPROS GMS ・ IPROS One of the largest technical database sites in Japan that collects information on.

Fibrosis drug - List of Manufacturers, Suppliers, Companies and Products

Fibrosis drug Product List

1～2 item / All 2 items

Displayed results
Tohoku University Technology: Organ Fibrosis Inhibitor: T13-204

Tohoku University Technology: Organ Fibrosis Inhibitor: T13-204

Confirmed the effects of fibrosis and inflammation improvement in a kidney fibrosis model mouse!

When the kidneys are damaged for some reason, it is known that inflammation and fibrosis can occur. As symptoms progress, kidney failure can develop, necessitating regular dialysis. Dialysis places a significant burden on patients, and there is a desire for the development of therapeutic drugs that can delay the initiation of dialysis. The inventors have discovered compounds with anti-inflammatory and anti-fibrotic effects. The group of compounds in this invention is expected to be utilized as fibrosis inhibitors.

  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Scleroderma Treatment Solutions

[Research Material] Global Market for Scleroderma Treatment Solutions

Global Market for Scleroderma Treatment Solutions: Immunotherapy, Antifibrotic Drugs, Others, Hospitals, Clinics, Others

This research report (Global Scleroderma Therapy Solutions Market) investigates and analyzes the current status and outlook for the global market for scleroderma treatment solutions over the next five years. It includes information on the overview of the global scleroderma treatment solutions market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include immunotherapy, anti-fibrotic drugs, and others, while the segments by application focus on hospitals, clinics, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for scleroderma treatment solutions. It also includes the market share of major companies in the scleroderma treatment solutions sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

Related Categories of Fibrosis drug

COPYRIGHT © 2001-2026 IPROS CORPORATION ALL RIGHTS RESERVED.